                               SEQUENCE LISTING

<110> COGEN IMMUNE MEDICINE, INC.
 
<120> PEPTIDE LIBRARIES AND METHODS OF USE THEREOF

<130> 56813-710.601

<140> PCT/US2020/012234
<141> 2020-01-03

<150> 62/791,601
<151> 2019-01-11

<150> 62/788,678
<151> 2019-01-04

<160> 22    

<170> PatentIn version 3.5

<210> 1
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Gly Gly Gly Gly Ser 
1               5   


<210> 2
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Gly Gly Gly Gly Gly Gly 
1               5       


<210> 3
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Gly Gly Gly Gly Gly Gly Gly Gly 
1               5               


<210> 4
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Lys Glu Ser Gly Ser Val Ser Ser Glu Gln Leu Ala Gln Phe Arg Ser 
1               5                   10                  15      


Leu Asp 
        


<210> 5
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Glu Gly Lys Ser Ser Gly Ser Gly Ser Glu Ser Lys Ser Thr 
1               5                   10                  


<210> 6
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Gly Ser Ala Gly Ser Ala Ala Gly Ser Gly Glu Phe 
1               5                   10          


<210> 7
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Asp Asp Asp Asp Lys 
1               5   


<210> 8
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (1)..(25)
<223> This sequence may encompass 2-5 "Glu Ala Ala Ala Lys"
      repeating units

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 8
Glu Ala Ala Ala Lys Glu Ala Ala Ala Lys Glu Ala Ala Ala Lys Glu 
1               5                   10                  15      


Ala Ala Ala Lys Glu Ala Ala Ala Lys 
            20                  25  


<210> 9
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (2)..(26)
<223> This region may encompass 2-5 "Glu Ala Ala Ala Lys"
      repeating units

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 9
Ala Glu Ala Ala Ala Lys Glu Ala Ala Ala Lys Glu Ala Ala Ala Lys 
1               5                   10                  15      


Glu Ala Ala Ala Lys Glu Ala Ala Ala Lys Ala 
            20                  25          


<210> 10
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220>
<221> MISC_FEATURE
<222> (1)..(10)
<223> This sequence may encompass 2-5 "Xaa Pro"
      repeating units

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 10
Xaa Pro Xaa Pro Xaa Pro Xaa Pro Xaa Pro 
1               5                   10  


<210> 11
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Cys Pro Arg Ser Cys 
1               5   


<210> 12
<211> 9
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Cytomegalovirus sequence

<400> 12
Asn Leu Val Pro Met Val Ala Thr Val 
1               5                   


<210> 13
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> N-formylmethionine

<400> 13
Met Asn Leu Val Pro Met Val Ala Thr Val 
1               5                   10  


<210> 14
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(7)
<223> Any amino acid

<400> 14
Asn Leu Xaa Xaa Xaa Xaa Xaa Thr Val 
1               5                   


<210> 15
<211> 14
<212> PRT
<213> Homo sapiens

<400> 15
Cys Ala Ala Asp Pro Ser Asp Ser Trp Gly Lys Leu Gln Phe 
1               5                   10                  


<210> 16
<211> 10
<212> PRT
<213> Homo sapiens

<400> 16
Cys Ala Phe Asn Asp Tyr Lys Leu Ser Phe 
1               5                   10  


<210> 17
<211> 14
<212> PRT
<213> Homo sapiens

<400> 17
Cys Ala Gly Pro Met Lys Thr Ser Tyr Asp Lys Val Ile Phe 
1               5                   10                  


<210> 18
<211> 13
<212> PRT
<213> Homo sapiens

<400> 18
Cys Ala Val Val Asp Asn Tyr Gly Gln Asn Phe Val Phe 
1               5                   10              


<210> 19
<211> 16
<212> PRT
<213> Homo sapiens

<400> 19
Cys Ala Ser Ser Glu Ser Arg Ile Leu Thr Tyr Asn Glu Gln Phe Phe 
1               5                   10                  15      


<210> 20
<211> 14
<212> PRT
<213> Homo sapiens

<400> 20
Cys Ala Trp Val Pro Gly Thr Gly Gly Thr Glu Ala Phe Phe 
1               5                   10                  


<210> 21
<211> 12
<212> PRT
<213> Homo sapiens

<400> 21
Cys Ala Ser Ala Ser Ala Asn Tyr Gly Tyr Thr Phe 
1               5                   10          


<210> 22
<211> 11
<212> PRT
<213> Homo sapiens

<400> 22
Cys Ala Ser Ser Ser Val Gly Ala Trp Thr Phe 
1               5                   10      


